June 2, 2021 BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors
May 28, 2021 BetterLife Closes $6.325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option
April 8, 2021 Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor
March 11, 2021 BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
March 8, 2021 BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
March 3, 2021 BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
February 2, 2021 BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
